secwatch / observer
8-K filed April 25, 2024, 7:59 PM ET ticker DXCM CIK 0001093557
earnings confidence high sentiment positive materiality 0.80

Dexcom Q1 revenue up 24% to $921M; GAAP EPS $0.36; updates FY guidance to $4.2-4.35B

DEXCOM INC

2024-Q1 EPS reported $0.36 revenue$921,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

DEXCOM INC reported the quarter ended March 31, 2024 results: revenue $921.0 million, net income $146.4 million, or $0.36 per diluted share, EPS $0.36 per diluted share. Guidance reaffirmed.

Period
the quarter ended March 31, 2024
Revenue
$921.0 million
Net income
$146.4 million, or $0.36 per diluted share
EPS
$0.36 per diluted share
Guidance
reaffirmed
Result
reported results
Exact text from the filing
(Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: • Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an organic 1 basis. • U.S. revenue and international revenue both grew 24% on a reported basis and international revenue grew 26% on
View on SEC.gov

1427 earnings releases filed in the last 30 days. Browse all earnings releases →

DEXCOM INC filing history →

Source: SEC EDGAR
accession 0001093557-24-000078
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.